| Product NDC: | 0310-0210 |
| Proprietary Name: | ZOMIG |
| Non Proprietary Name: | Zolmitriptan |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Zolmitriptan |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0310-0210 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020768 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980110 |
| Package NDC: | 0310-0210-20 |
| Package Description: | 6 BLISTER PACK in 1 CARTON (0310-0210-20) > 6 TABLET in 1 BLISTER PACK |
| NDC Code | 0310-0210-20 |
| Proprietary Name | ZOMIG |
| Package Description | 6 BLISTER PACK in 1 CARTON (0310-0210-20) > 6 TABLET in 1 BLISTER PACK |
| Product NDC | 0310-0210 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Zolmitriptan |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19980110 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | ZOLMITRIPTAN |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |